READ-ONLY DIGITIZATION RESULT
Neoadjuvant chemoradiotherapy with capecitabine and irinotecan guided by UGT1A1 status in patients with locally advanced rectal cancer: 5-year update of the CinClare trial.
Cancer Commun (Lond) · 2025-Nov · PMID 40899645
Panel _D_提取失败待 EXE 对齐验证
OS
FIGURE 5 Survival outcomes by pCR status in two treatment arms. (A‐D) Kaplan‐Meier curves for LC, DMFS, DFS and OS of the pCR subgroup, respectively. (E‐H) Kaplan‐Meier curves for LC, DMFS, DFS and OS of the non‐pCR subgroup, respectively. Among patients who achieved pCR, outcomes were similar between the CapIriRT and CapRT groups. However, among patients who did not achieve pCR, the CapIriRT group had slightly longer LC, DMFS, and DFS compared to the CapRT group. Abbreviations: DFS, disease‐free survival; DMFS, distant metastasis‐free survival; LC, local control; OS, overall survival; pCR, pathologic complete response.
算法:legacy-0.5.0引擎:enhanced-linux
No curves extracted
曲线数据
网页最多预览 200 行,完整数据请下载 CSV 或 JSON。
当前面板没有可预览的 `curves_mapped.csv` 数据。
历史版本(1)
重跑只新增版本,不覆盖旧结果;正式可用状态仅授予通过 EXE 基准或人工复核的版本。
| 版本 | 状态 | 验证 | 曲线 | 时间 |
|---|---|---|---|---|
| legacy-0.5.0 | failed | 待验证 | 0 | 2026-07-23T17:18:26+00:00 |